Roflumilast foam 0.3% for adolescent and adult patients with seborrheic dermatitis: A phase 3 trial
收藏NIAID Data Ecosystem2026-05-01 收录
官方服务：
资源简介：
Supplementary data to support the primary manuscript “Roflumilast foam 0.3% for adolescent and adult patients with seborrheic dermatitis: A randomized, double-blind, vehicle-controlled, phase 3 trial”
创建时间：
2024-04-18
